Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1914-65-4 | MDL No. : | MFCD02179127 |
Formula : | C11H12O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VDLWTJCSPSUGOA-UHFFFAOYSA-N |
M.W : | 176.21 | Pubchem ID : | 12598146 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.36 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 50.45 |
TPSA : | 37.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.71 cm/s |
Log Po/w (iLOGP) : | 1.65 |
Log Po/w (XLOGP3) : | 2.35 |
Log Po/w (WLOGP) : | 2.19 |
Log Po/w (MLOGP) : | 2.18 |
Log Po/w (SILICOS-IT) : | 2.28 |
Consensus Log Po/w : | 2.13 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.69 |
Solubility : | 0.361 mg/ml ; 0.00205 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.77 |
Solubility : | 0.297 mg/ml ; 0.00169 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.65 |
Solubility : | 0.398 mg/ml ; 0.00226 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.34 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43.6% | With quinine In ethanol at 0 - 50℃; for 0.5 h; | 15.6 g, 0.1 mol of 1,2,3,4-tetrahydronaphthoic acid and 29.8 g, 0.1 mol of quinine were added to 158 ml of 50 V / Vpercent ethanol, stirred at 50 ° C for 30 minutes to dissolve the solution, TLC detection The reaction is complete, PE: EA = 1:2, and the temperature is lowered to below 0 °C for overnight, crystallization, suction filtration, drying, and then adding 90 ml of ethanol to refine, crystallization at 0 ° C, suction filtration, drying, adding 55 ml1 mol / L hydrochloric acid and 100 ml of ethyl acetate, liquid separation, drying, filtration, concentration, the residue was recrystallized from n-hexane to give(S)-1,2,3,4-tetrahydronaphthoic acid white solid 7.21g,The yield was 43.6percent, |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 7(+/-) 1,2,3,4-Tetrahydro-1-naphthoic acid ethyl ester 1,2,3,4-Tetrahydro-1-naphthalenecarbonitrile (408 mg, 2.6 mmol) was dissolved in 5 M KOH in isopropanol (10 mL) and heated to 100 C. overnight and then cooled to room temperature and acidified with 6 M hydrochloric acid. The solution was then extracted three times with diethylether before the combined ethereal extracts were extracted 3 times with aqueous saturated NaHCO3. The NaHCO3 were acidified with hydrochloric acid and extracted 3 times with CH2Cl2, which were dried over MgSO4, filtered and concentrated under reduced pressure. The remaining material was dissolved in dry CH3CN (3 mL) and ethyl bromide (0.28 mL, 3.7 mmol) and Cs2CO3 (608 mg, 1.87 mmol) were added and the reaction mixture heated to reflux for 2 hours. The resulting slurry was filtered and the filtrate concentrated under reduced pressure before taken up in CH2Cl2 (30 mL) and washed with water (30 mL). The organic layer was dried over MgSO4, filtered, concentrated and purified by column chromatography on silica (CH2Cl2/pentane 1:1) to give racemic 1,2,3,4-tetrahydro-1-naphthoic acid ethyl ester (240 mg, 45%)Racemic: 1H-NMR (CDCl3, 400 MHz) deltaH 7.19-7.09 (m, 4H), 4.18 (q, 2H, J 7.2 Hz), 3.81 (t, 1H, J 6.0 Hz), 2.88-2.72 (m, 2H), 2.18-2.09 (m, 1H), 2.05-1.94 (m, 2H), 1.80-1.72 (m, 1H), 1.27 (t, 3H, J 7.2 Hz).13C-NMR (CDCl3, 100 MHz) deltaC 174.9, 137.2, 133.4, 129.4, 129.2, 126.8, 125.7, 60.8, 44.9, 29.2, 26.7, 20.7, 14.3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In acetonitrile; at 20℃; | While stirring (1RS,2SR)-2-amino-1-(4-fluorophenyl)-3-[4-(trifluoromethyl)phenyl]propan-1-ol (0.168 g, 0.536 mmol), 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (seeTetrahedron, 53, 15969-15982 (1990))(94 mg, 0.54 mmol) and 1-hydroxybenzotriazole hydrate (82 mg, 0.54 mmol) in acetonitrile (10 ml), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.10 g, 0.54 mmol) was added, and the mixture was stirred overnight at room temperature. The reaction solution was diluted with ethyl acetate, washed with aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate and passed through silica gel. The solvent was evaporated under reduced pressure and the obtained residue was crystallized from ethyl acetate-hexane to give the objective substance. white crystal yield 0.161 g, 64% mp 219-221C; 1H-NMR (CDCl3-DMSO-d6, 200MHz) delta 1.50-1.73 (4H, m) , 2.05-2.35 (2H, m), 2.70 (2H, t, J = 6.4 Hz), 2.88 (1H, dd, J = 10.8 Hz, 14.4 Hz), 3.06 (1H! , dd, J = 3.8 Hz, 14.0 Hz), 4.55-4.70 (1H, m), 4.87 (1H, t, J = 4.4 Hz) , 5.33 (1H, d, J = 3.6 Hz), 6.74 (1H, dd, J = 2.8 Hz, 5.6 Hz), 6.95-7.09 (4H, m), 7.28-7.37 (3H, m), 7.47-7.54 (4H, m); IR (KBr) 3330, 1624, 1534, 1329, 1159, 1123, 1069, 831 cm-1; Anal. Calcd for C27H25F4NO2: C, 68.78; H, 5.34; N, 2.97. Found: C, 68.62; H, 5.38; N, 2.90. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
EXAMPLE 138 5-(1,2,3,4-tetrahydronaphth-1-oyl)amino-3-(1-methylpiperidin-4-yl)-1H-indole Beginning with 12.0 mg (0.05 mMol) 5-amino-3-(1-methylpiperidin-4-yl)-1H-indole with 16.2 mg (0.10 mMol) 1,2,3,4-tetrahydro-1-naphthoic acid at 70 C., 16.2 mg (84%) of the title compound were recovered. MS(m/e): 388(M+1) | ||
EXAMPLE 138 5-(1,2,3,4-tetrahydronaphth-1-oyl)amino-3-(1-methylpiperidin-4-yl)-1H-indole Beginning with 12.0 mg (0.05 mMol) 5-amino-3-(1-methylpiperidin-4-yl)-1H-indole with 16.2 mg (0.10 mMol) 1,2,3,4-tetrahydro-1-naphthoic acid at 70C, 16.2 mg (84%) of the title compound were recovered. MS(m/e): 388(M+1) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydroxide; In water; ethyl acetate; N,N-dimethyl-formamide; toluene; | EXAMPLE 3 N-(1- Azabicyclo[2.2.2]oct-3S-yl)-1,2,3,4 -tetrahydronaphthalen-1-ylcarboxamide A mixture of 1,2,3,4-tetrahydro-1-naphthoic acid (207.75 g, 1.18 mol), prepared as in Example 1, and thionyl chloride (13.7M, 92.89 mL, 1.27 mol) in 20 drops of N,N-dimethylformamide and 795 mL of toluene was stirred for 1 hour at 25 C. and for 1 hour at 50 C. The mixture was distilled to a volume of approximately 500 mL and then diluted with 300 mL of toluene. (S)-1-Azabicyclo[2.2.2]oct-3-ylamine (148.83 g, 1.16 mol) in 2.895 L of ethyl acetate was added and the mixture was stirred for 1 hour at 50 C. The mixture was allowed to cool to room temperature and 2 L of water and 93.4 mL of 50% sodium hydroxide were added. The aqueous layer was separated and extracted with ethyl acetate (2*1.5 L). The combined ethyl acetate layers were dried (NaSO4), filtered and concentrated to give N-(1-azabicyclo[2.2.2]oct-3S-yl)-1,2,3,4-tetrahydronaphthalen-1-ylcarboxamide (350.3 g, 1.23 mol), m.p. 190.1-191.2 C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62.7% | EXAMPLE 74 1-Methyl-4-[3-(1,2,3,4-tetrahydro-1-naphthoyloxy)-benzoyl]piperazine.hydrochloride The same procedure as in Example 65 was repeated using 1-methyl-4-(3-hydroxybenzoyl)piperazine and 1,2,3,4-tetrahydro-1-naphthylcarboxylic acid to obtain the title compound having a melting point of 218-220 C. as needle-like pale yellow crystals (yield: 62.7%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; sodium hydroxide; In diethyl ether; | In a 3000 ml. four-necked flask equipped with a thermometer, a stirrer, a dropping funnel and a gas inlet tube, 500 ml. of diethyl ether were charged; and, while cooling in an ice bath, carbon dioxide gas was passed through and dissolved in the ether. Subsequently, while passing CO2 gas, the dispersion of 1,2,3,4-tetrahydro-1-naphthyl sodium was added dropwise at a temperature not exceeding 40 C., followed by continued stirring for an hour while passing carbon dioxide gas. To the resulting mixture, was added 800 ml. of 0.5N aqueous solution of sodium hydroxide. The mixture was stirred vigorously, and was then allowed to separate into an organic phase and an aqueous phase. Hydrochloric acid was added slowly to the aqueous phase to adjust the phase to a pH of 1-2, whereby a white precipitate formed. The precipitate was filtered with suction and dried to obtain 129 g. of crude 1,2,3,4-tetrahydro-1-naphthoic acid. The crude acid was recrystallized from a mixture of methanol and water to obtain 120 g. of colorless needles of 1,2,3,4-tetrahydro-1-naphthoic acid having the following properties: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With triethylamine; In dichloromethane; | EXAMPLE 4 This example describes the preparation of N-(p-chloro-alpha-ethyl-alpha-methylbenzyl)-1,2,3,4-tetrahydro-alpha-naphthoamide [Compound No. III-22]. In a 200 ml. round bottom flask equipped with a thermometer, a stirrer and a reflux condenser, 2.64 g. of 1,2,3,4-tetrahydro-alpha-naphthoic acid, produced according to Example 2, were dissolved into 90 ml. of methylene chloride. To the mixture were added 2.75 g. of p-chloro-alpha-ethyl-alpha-methylbenzyl amine, 3.64 g. of triethyl amine and 4.59 g. of N-methyl-2-chloropyridinium iodide in order, followed by heating to reflux temperature for an hour and then cooling to room temperature. To the resulting product, 30 ml. of 5% hydrochloric acid was added, followed by removal of the solvent by distillation under reduced pressure. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With thionyl chloride; In dichloromethane; 1,2-dichloro-ethane; | Example 4 To a solution of 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (3.3 g) in 1,2-dichloroethane (20 mL) was added thionyl chloride (2.1 mL), and the mixture was heated under reflux with stirring for 3 hr. The reaction mixture was concentrated under reduced pressure, and methylene chloride (10 mL) was added to the residue. This solution was added to a solution of [(4-dimethylaminophenyl)methyl](4-isopropylphenyl)amine (5.1 g) in methylene chloride (10 mL) under ice-cooling. The reaction mixture was warmed to room temperature and stirred at the same temperature for one day. The reaction mixture was partitioned between water and ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was evaporated, and the residue was purified by silica gel column chromatography. The obtained crystals were recrystallized from isopropyl ether to give N-[(4-dimethylaminophenyl)methyl]-N-(4-isopropylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (4.38 g). melting point: 121ØC |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 23 By the reaction and treatment in the same manner as in Example 1 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.5 g) and [(1-ethylpyrazol-4-yl)methyl](4-isopropylphenyl)amine (0.57 g) as starting materials, N-[(1-ethylpyrazol-4-yl)methyl]-N-(4-isopropylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.12 g) was obtained. melting point: 75-76ØC |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With thionyl chloride; triethylamine; In tetrahydrofuran; dichloromethane; | Example 1 To a solution of 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (1.0 g) in methylene chloride (10 mL) was added thionyl chloride (0.68 mL), and the mixture was heated under reflux with stirring for 3 hr. The reaction mixture was concentrated under reduced pressure, and THF (6 mL) was added to the residue. This solution was added to a solution of [(4-dimethylaminophenyl)methyl] (4-ethylphenyl)amine (1.2 g) and triethylamine (2 mL) in THF (6 mL) under ice-cooling. The mixture was allowed to warm to room temperature and stirred at the same temperature for one day. The reaction mixture was partitioned between water and ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was evaporated, and the residue was purified by silica gel column chromatography. The obtained crystals were recrystallized from a mixed solvent of ethyl acetate and hexane to give N-[(4-dimethylaminophenyl)methyl]-N-(4-ethylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.28 g). melting point: 109-110ØC |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With thionyl chloride; In tetrahydrofuran; dichloromethane; | Example 5 To a solution of 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.24 g) in methylene chloride (3 mL) was added thionyl chloride (0.15 mL), and the mixture was heated under reflux with stirring for 3 hr. The reaction mixture was concentrated under reduced pressure, and THF (2 mL) was added to the residue. This solution was added to a solution of (5-bromo-2-isobutoxyphenyl)[(4-dimethylaminophenyl)methyl]amine (0.5 g) and sodium hydride (0.07 g) in THF (3 mL). The reaction mixture was warmed to room temperature and stirred at the same temperature for one day. The reaction mixture was partitioned between water and ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was evaporated, and the residue was purified by silica gel column chromatography. The obtained crystals were recrystallized from ethyl acetate to give N-(5-bromo-2-isobutoxyphenyl)-N-[(4-dimethylaminophenyl)methyl]-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.3 g). melting point: 176-178ØC |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 27 By the reaction and treatment in the same manner as in Example 1 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (1.0 g) and [(4-chlorophenyl)methyl](4-isopropylphenyl)amine (1.3 g) as starting materials, N-[(4-chlorophenyl)methyl]-N-(4-isopropylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.1 g) was obtained. melting point: 122-123ØC |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 33 By the reaction and treatment in the same manner as in Example 4 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.5 g) and [(1-ethyl-3,5-dimethylpyrazol-4-yl)methyl](4-isopropylphenyl)amine (0.65 g) as starting materials, N-[(1-ethyl-3,5-dimethylpyrazol-4-yl)methyl]-N-(4-isopropylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.31 g) was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 149 By the reaction and treatment in the same manner as in Example 12 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.70 g) and (4-butylphenyl)[(4-dimethylaminophenyl)methyl]amine (0.54 g) as starting materials, N-(4-butylphenyl)-N-[(4-dimethylaminophenyl) methyl]-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.81 g) was obtained. 1H-NMR(CDCl3)delta: (0.92 (3H,t,J=7.4Hz), 1.26-1.37(2H,m), 1.50-1.52(1H,m), 1.55-1.64(2H,m), 1.89-1.91(1H,m), 1.95-2.04(2H,m), 2.58(2H,t,J=7.4Hz), 2.65-2.67(1H,m), 2.82-2.85(1H,m), 2.94(6H,s), 3.70-3.75(1H,m), 4.72(1H,d,J=13.9Hz), 4.93(1H,d,J=13.9Hz), 6.63(2H,m), 6.94-7.13(10H,m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 270 By the reaction and treatment in the same manner as in Example 12 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.35 g) and (4-isopropylphenyl)[(1-phenylpyrazol-4-yl)methyl]amine (0.58 g) as starting materials, N-(4-isopropylphenyl)-N-[(1-phenylpyrazol-4-yl)methyl]-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.42 g) was obtained. 1H-NMR(CDCl3)delta: 1.25(6H,d,J=6.9Hz), 1.41-1.60(1H,m), 1.83-2.09(3H,m), 2.59-2.72(1H,m), 2.79-3.00(2H,m), 3.70-3.81(1H,m), 4.72(1H,d,J=14.4Hz), 4.89(1H,d,J=14.4Hz), 6.90-6.99(1H,m), 7.00-7.17(5H,m), 7.21-7.31(3H,m), 7.37-7.47(2H,m), 7.58(1H,s), 7.66(2H,d,J=9.0Hz), 7.94(1H,s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 120 By the reaction and treatment in the same manner as in Example 12 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.7 g) and [(5-ethylthiophen-2-yl)methyl](4-isopropylphenyl)amine (1.04 g) as starting materials, N-[(5-ethylthiophen-2-yl)methyl]-N-(4-isopropylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.18 g) was obtained. MS(ESI)m/z: 418[MH]+ 1H-NMR(CDCl3)delta: 1.24(6H,d,J=6.9Hz), 1.30(3H,t,J=7.5Hz), 1.40-1.60(1H,m), 1.80-2.10(3H,m), 2.55-2.70(1H,m), 2.82(2H,q,J=7.5Hz), 2.72-3.00(2H,m), 3.65-3.80(1H,m), 4.90 (1H,d,J=14.6Hz), 5.03(1H,d,J=14.6Hz), 6.56(1H,d,J=3.4Hz), 6.62(1H,d,J=3.4Hz), 6.90-7.30(8H,m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 150 By the reaction and treatment in the same manner as in Example 12 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.34 g) and (4-ethylphenyl)[(4-morpholinophenyl)methyl]amine (0.59 g) as starting materials, N-(4-ethylphenyl)-N-[(4-morpholinophenyl)methyl]-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.60 g) was obtained. 1H-NMR(CDCl3)delta: 1.22(3H,t,J=7.8Hz), 1.47-1.51(1H,m), 1.87-1.91(1H,m), 1.94-2.05(2H,m), 2.63(2H,q,J=7.8Hz), 2.59-2.67(1H,m), 2.80-2.85(1H,m), 3.16(4H,t,J=4.8Hz), 3.71-3.76(1H,m), 3.87(4H,t,J=4.8Hz), 4.75(1H,d,J=13.8Hz), 4.94(1H,d,J=13.8Hz), 6.81-6.84(2H,m), 6.95-7.17(10H,m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 151 By the reaction and treatment in the same manner as in Example 12 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.34 g) and (4-ethylphenyl)(2-piperidinoethyl)amine (0.47 g) as starting materials, N-(4-ethylphenyl)-N-(2-piperidinoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.65 g) was obtained. 1H-NMR(CDCl3)delta: 1.22-1.28(4H,m), 1.43-1.60(7H,m), 1.94-2.01(2H,m), 2.39-2.56(6H,m), 2.63-2.70(3H,m), 2.78-2.90(1H,m),3.61-3.75(2H,m), 4.10-4.17(1H,m), 7.00-7.13(3H,m), 7.18-7.28(5H,m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 153 By the reaction and treatment in the same manner as in Example 12 using 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (0.34 g) and [(4-benzyloxyphenyl)methyl] (4-isopropylphenyl) amine (0.66 g) as starting materials, N-[(4-benzyloxyphenyl)methyl]-N-(4-isopropylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (0.52 g) was obtained, melting point: 120-121ØC |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With thionyl chloride; triethylamine; In tetrahydrofuran; hexane; dichloromethane; | Preparation Example 11 To a solution of 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (2 g) in methylene chloride (10 mL) was added thionyl chloride (1 mL) and the mixture was heated under reflux with stirring for 3 hr. The reaction mixture was concentrated under reduced pressure, and THF (5 mL) was added to the residue. This solution was added to a solution of 4-isopropylaniline (1.53 g) and triethylamine (4.6 mL) in THF (10 mL) under ice-cooling. The temperature was raised to room temperature, and the mixture was stirred at the same temperature for 1 hr. The reaction mixture was partitioned between water and ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was evaporated and hexane was added to the residue. The precipitated solid was collected by filtration to give N-(4-isopropylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide (2.78 g). melting point: 163.1ØC |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | General procedure: To a solution of DCC (271 mg, 1.20 mmol) and DMAP (15 mg, 0.12 mmol) in CH2Cl2, acetic acid (66mg, 1.10 mmol) was added and the reaction mixture was stirred for 30 min, and then compound 2 (226 mg, 1.00 mmol) was added to this slurry. The mixture was stirred at room temperature overnight, then the white precipitate was filtered off and CH2Cl2 was removed in vacuo, the residue was purified on a silicagel chromatography column to get compound 3a (239 mg, 89%) as a red solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
6% | With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0℃; for 1h; | Example A58. N-(3-(3-sulfamoylphenvD- lH-indazol-5-yl)- 1 ,2.3.4-tetrahydronaphthalene- 1- carboxamideTo a mixture of 3-(5-amino-lH-indazol-3-yl)benzenesulfonamide trifluoroacetate (120 mg, 0.3 mmol), 1 ,2,3,4-tetrahydronaphthalene-l -carboxylic acid (53 mg, 0.3 mmol) and TBTU (96 mg, 0.3 mmol) in DMF (4 mL) at 0 C was added 'Pr2NEt (0.16 mL, 0.9 mmol). The resulting mixture was stirred for lh at 0 C, then filtered through microfilter and purified by preparative HPLC. The title compound was obtained as a white solid (8 mg, 6%) after trituration-139-44820V.1 with MeOH. NMR (400 MHz, DMSO-d6) delta 13.40 (s, IH), 10.36 (s, IH), 8.50 (s, IH), 8.41 (s, IH), 8.08 (d, 7 =6.8 Hz, IH), 7.82 (d, 7 =8.0 Hz, IH), 7.72 (t, 7 =8.0 Hz, IH), 7.63 (d, 7 =8.0 Hz, IH, partially overlapping with the doublet at 7.59 ppm), 7.59 (d, 7 =8.0 Hz, IH, partially overlapping with the doublet at 7.63 ppm), 7.48 (s, 2H, NH2), 7.16-7.08 (m, 4H), 3.89 (t, 7 =4.8 Hz, IH), 2.82-2.68 (m, 2H), 2.10-2.00 (m, 3H), 1.73-1.63 (m, IH); MS ESI 447.3 [M + H]+, calcd for [C24H22N4O3S + H]+ 447.1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 7(+/-) 1,2,3,4-Tetrahydro-1-naphthoic acid ethyl ester 1,2,3,4-Tetrahydro-1-naphthalenecarbonitrile (408 mg, 2.6 mmol) was dissolved in 5 M KOH in isopropanol (10 mL) and heated to 100 C. overnight and then cooled to room temperature and acidified with 6 M hydrochloric acid. The solution was then extracted three times with diethylether before the combined ethereal extracts were extracted 3 times with aqueous saturated NaHCO3. The NaHCO3 were acidified with hydrochloric acid and extracted 3 times with CH2Cl2, which were dried over MgSO4, filtered and concentrated under reduced pressure. The remaining material was dissolved in dry CH3CN (3 mL) and ethyl bromide (0.28 mL, 3.7 mmol) and Cs2CO3 (608 mg, 1.87 mmol) were added and the reaction mixture heated to reflux for 2 hours. The resulting slurry was filtered and the filtrate concentrated under reduced pressure before taken up in CH2Cl2 (30 mL) and washed with water (30 mL). The organic layer was dried over MgSO4, filtered, concentrated and purified by column chromatography on silica (CH2Cl2/pentane 1:1) to give racemic 1,2,3,4-tetrahydro-1-naphthoic acid ethyl ester (240 mg, 45%)Racemic: 1H-NMR (CDCl3, 400 MHz) deltaH 7.19-7.09 (m, 4H), 4.18 (q, 2H, J 7.2 Hz), 3.81 (t, 1H, J 6.0 Hz), 2.88-2.72 (m, 2H), 2.18-2.09 (m, 1H), 2.05-1.94 (m, 2H), 1.80-1.72 (m, 1H), 1.27 (t, 3H, J 7.2 Hz).13C-NMR (CDCl3, 100 MHz) deltaC 174.9, 137.2, 133.4, 129.4, 129.2, 126.8, 125.7, 60.8, 44.9, 29.2, 26.7, 20.7, 14.3. |
Tags: 1914-65-4 synthesis path| 1914-65-4 SDS| 1914-65-4 COA| 1914-65-4 purity| 1914-65-4 application| 1914-65-4 NMR| 1914-65-4 COA| 1914-65-4 structure
[ 1135-67-7 ]
1-Phenylcyclohexanecarboxylic acid
Similarity: 0.97
[ 13491-13-9 ]
(R)-3-Methyl-2-phenylbutanoic acid
Similarity: 0.97
[ 3508-94-9 ]
alpha-Isopropylphenylacetic Acid
Similarity: 0.97
[ 13490-69-2 ]
(S)-3-Methyl-2-phenylbutanoic acid
Similarity: 0.97
[ 1135-67-7 ]
1-Phenylcyclohexanecarboxylic acid
Similarity: 0.97
[ 13491-13-9 ]
(R)-3-Methyl-2-phenylbutanoic acid
Similarity: 0.97
[ 3508-94-9 ]
alpha-Isopropylphenylacetic Acid
Similarity: 0.97
[ 13490-69-2 ]
(S)-3-Methyl-2-phenylbutanoic acid
Similarity: 0.97
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :